BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21877752)

  • 21. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
    Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma.
    Attallah AM; El-Far M; Abdel Malak CA; Zahran F; Farid K; Omran MM; Zagloul H; El-Deen MS
    Clin Chim Acta; 2011 Nov; 412(23-24):2310-5. PubMed ID: 21924253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential tumor markers and hepatitis markers profile in liver tumors.
    Khalifa A; Mady EA; Abadeer N; Kamal A
    Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
    Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
    J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
    Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma.
    Nafee AM; Pasha HF; Abd El Aal SM; Mostafa NA
    Clin Biochem; 2012 Sep; 45(13-14):1070-4. PubMed ID: 22580393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
    Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
    Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma and their significance in clinical settings].
    Tong GD; Zhou DQ; He JS; Xiao CL; Liu XL; Zhou XZ; Zhang X; Xing YF; Lü P; Feitelson MA
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):828-32. PubMed ID: 18073065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
    Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
    J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
    Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.